Read More Pharma Industry News CytoAgents, Quotient Sciences to take COVID-19 drug candidate GP1681 into human trials US biotech company CytoAgents has joined forces with CDMO and CRO services provider Quotient Sciences to accelerate the development… bypharmanewsdailyApril 29, 2020
